This refresh
Data-driven refresh June 5, 2026. Top 5 per bucket by live Bull Rankings score across a 5182-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2513 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative authored by Groq (with Gemini and data-driven fallbacks). Intraday re-ranking from a top-30 per-bucket shortlist.
Growth — high-quality compounders
1. KGC — Kinross Gold Corporation · score 100
Gold · price $26.22 · 1Y $40.91 · 5Y $42.23 · 10Y $62.07
FCF $3.0b B · Rev +36.9% A · D/E 0.08 A- · P/E 11.2x A · PEG 1.12 B+
Why now. Kinross Gold Corporation, a mid-cap gold miner, is positioned for growth with a 36.9% revenue growth rate and a 11.2 P/E ratio, indicating a reasonable valuation. The company's $3.0B in free cash flow and 35.5% return on equity suggest a strong ability to generate profits. As a gold producer, KGC sells its output to various customers, including refineries, banks, and other financial institutions, in a sector with inherent volatility but also potential for long-term growth.
Moat. Kinross Gold Corporation's moat stems from its diversified production geographies and its ability to maintain a 36% profit margin, which is driven by its cost advantages and operational efficiencies. The company's 35.5% return on equity is a result of its pricing power, which is derived from its position as a significant player in the gold mining sector. This allows KGC to navigate the sector's economics and maintain its competitive position.
Risk. The main risks facing Kinross Gold Corporation include its 1.35 beta, indicating a higher volatility compared to the broader market, and its 0.08 debt-to-equity ratio, which, although low, still poses a risk if interest rates rise or the company's cash flow deteriorates. Additionally, the company's growth is tied to the gold price, which can be highly volatile and subject to various market and economic factors.
Horizon. 1-3 yr $40.91 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $42.23 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $62.07 if current growth sustains into durable earnings power.
2. FSM — Fortuna Mining Corp. · score 98
Gold · price $8.69 · 1Y $9.99 · 5Y $14.00 · 10Y $20.57
FCF $563m C+ · Rev +39.8% A · D/E 0.11 A- · P/E 8.0x A · PEG n/a
Why now. Fortuna Mining Corp., a mid-cap gold miner, is poised for growth driven by its 39.8% revenue growth rate and 31.1% profit margin, with a current price of $8.69 and a P/E of 8. The company's free cash flow of $563m and debt-to-equity ratio of 0.11 demonstrate its financial health. With an analyst consensus target of $14, the stock has potential for upside.
Moat. Fortuna Mining Corp.'s moat is rooted in its ability to generate a 22% return on equity, driven by its pricing power in the gold sector. As a category leader, the company benefits from its diversified production geographies and low debt levels, allowing it to maintain a competitive edge. The company's high profit margin and free cash flow yield also contribute to its moat, making it an attractive investment opportunity.
Risk. The main risks facing Fortuna Mining Corp. include its high beta of 2.08, indicating volatility, and its debt-to-equity ratio, which, although low, could still pose a risk if the company's financials deteriorate. Additionally, the company's reliance on the gold sector makes it vulnerable to fluctuations in gold prices and sector trends.
Horizon. 1-3 yr $9.99 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $14.00 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $20.57 if current growth sustains into durable earnings power.
3. DLO — DLocal Limited · score 96
Software - Infrastructure · price $11.24 · 1Y $17.35 · 5Y $18.10 · 10Y $26.61
FCF $374m C · Rev +46.6% A · D/E 0.20 B+ · P/E 17.6x A- · PEG n/a
Why now. DLocal Limited, a software infrastructure company, is currently trading at a $11.24 price point with a 17.6 P/E ratio, indicating a relatively reasonable valuation given its 46.6% revenue growth rate. The company's high 15.8% profit margin and 35% ROE suggest a strong business model. With an analyst consensus 1-yr target of $17.35, there is potential for upside.
Moat. DLocal's moat is driven by its high ROE, which can be attributed to its 15.8% profit margin and efficient business model. The company's 35% ROE is a result of its ability to generate strong cash flows, with $374m in free cash flow over the last twelve months. This cash flow generation capability allows the company to invest in its business and maintain its competitive position.
Risk. One of the key risks facing DLocal is its 0.96 beta, indicating a relatively high level of market sensitivity. Additionally, the company's 0.2 debt-to-equity ratio, while relatively low, still poses a risk if interest rates were to rise. The company's reliance on a few key markets or customers could also pose a risk if those markets were to experience a downturn.
Horizon. 1-3 yr $17.35 (analyst consensus (n=10)) — fundamentals + valuation re-rating. 5 yr $18.10 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $26.61 if current growth sustains into durable earnings power.
4. GPOR — Gulfport Energy Corporation · score 95
Oil & Gas E&P · price $168.06 · 1Y $242.00 · 5Y $270.66 · 10Y $397.86
FCF $362m C · Rev +42.5% A · D/E 0.46 B · P/E 5.5x A · PEG n/a
Why now. Gulfport Energy Corporation, an Oil & Gas E&P company, is currently trading at a $168.06 price with a 5.5 P/E ratio, indicating a relatively low valuation. The company has a high revenue growth rate of 42.5%, driven by its strong position in the energy sector. With an analyst consensus 1-yr target of $242, there is a potential upside for investors, especially considering the company's 42.1% profit margin and 34% ROE.
Moat. Gulfport Energy Corporation's moat is rooted in its ability to generate high returns on equity, with an ROE of 34%, driven by its pricing power and cost advantages in the Oil & Gas E&P sector. The company's $362m in free cash flow also provides a cushion for potential disruptions. Additionally, its 0.46 debt-to-equity ratio suggests a manageable level of debt, allowing the company to invest in growth initiatives.
Risk. One of the key risks facing Gulfport Energy Corporation is its exposure to fluctuations in energy prices, which could impact its revenue growth. The company's 0.4 beta suggests a relatively low level of volatility, but the 42.5% revenue growth rate may be difficult to sustain. Additionally, the company's $3.0b market cap may make it more susceptible to market fluctuations.
Horizon. 1-3 yr $242.00 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $270.66 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $397.86 if current growth sustains into durable earnings power.
5. ATAT — Atour Lifestyle Holdings Limited · score 94
Lodging · price $33.42 · 1Y $50.48 · 5Y $53.82 · 10Y $79.12
FCF $327m C · Rev +35.1% A · D/E 0.37 A- · P/E 17.1x B+ · PEG n/a
Why now. Atour Lifestyle Holdings Limited, a growth company in the Lodging sector, is currently trading at a $33.42 price point with a 17.1 P/E ratio, indicating a reasonable valuation. The company's 35.1% revenue growth rate and $327m in free cash flow demonstrate its ability to drive growth and generate cash. With an analyst consensus 1-yr target of $50.48, there is potential for significant upside.
Moat. Atour Lifestyle Holdings Limited's durable competitive advantage is driven by its 52.9% ROE, which is attributed to its pricing power and ability to maintain a 17.2% profit margin. The company's business model in the Lodging sector allows it to benefit from a 0.63 beta, indicating a relatively low volatility. The company's 2.9 PS ratio also suggests a reasonable valuation relative to its sales.
Risk. The main risks facing Atour Lifestyle Holdings Limited include its 0.37 debt-to-equity ratio, which may increase its financial leverage and vulnerability to interest rate changes. Additionally, the company's 17.1 P/E ratio may be considered elevated, making it susceptible to multiple compression. The company's growth rate may also be impacted by external factors, such as changes in the Lodging sector's demand and supply dynamics.
Horizon. 1-3 yr $50.48 (analyst consensus (n=16)) — fundamentals + valuation re-rating. 5 yr $53.82 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $79.12 if current growth sustains into durable earnings power.
Value — quality at a discount
1. AU — AngloGold Ashanti plc · score 100
Gold · price $84.12 · 1Y $119.86 · 5Y $112.57 · 10Y $143.69
FCF $4.2b B · Rev +70.8% A · D/E 0.22 B+ · P/E 12.4x A- · PEG 0.78 A-
Why now. AngloGold Ashanti plc, a gold sector company, offers an attractive setup with a current price of $84.12, a P/E of 12.4, and a revenue growth rate of 70.8%. The company's profit margin of 31.1% and ROE of 43% demonstrate its ability to generate significant earnings from its operations. With an analyst consensus 1-yr target of $119.86, the stock has potential for re-rating.
Moat. AngloGold Ashanti's moat is rooted in its ability to generate significant free cash flow, with $4.2B in FCF over the last twelve months. This is a result of its pricing power, driven by its position in the gold sector, as well as its cost advantages in production. The company's debt-to-equity ratio of 0.22 also provides a stable financial foundation, allowing it to invest in its operations and return value to shareholders.
Risk. The main risks facing AngloGold Ashanti include its beta of 0.64, indicating a moderate level of volatility, as well as the potential for fluctuations in gold prices. Additionally, the company's revenue growth rate of 70.8% may be difficult to sustain, and any decline in growth could negatively impact the stock price. The analyst recommendation mean of 2 also suggests that there may be some uncertainty among analysts regarding the company's future prospects.
Horizon. 1-3 yr $119.86 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $112.57 at ~6% CAGR — dividend + buyback compounding. 10 yr $143.69 if the moat survives secular pressure.
2. PDD — PDD Holdings Inc. · score 98
Internet Retail · price $85.07 · 1Y $120.50 · 5Y $113.84 · 10Y $145.31
FCF $15.8b A- · Rev +9.7% B · D/E 0.01 A · P/E 8.9x A · PEG 0.82 B+
Why now. PDD Holdings Inc., an Internet Retail company, presents a compelling value proposition with its current price of $85.07, a P/E of 8.9, and a 21.6% profit margin. The company's $15.8B in free cash flow and 9.7% revenue growth rate suggest a strong financial foundation. As an undervalued franchise, PDD's re-rating catalyst could be its low debt-to-equity ratio of 0.01 and analyst consensus 1-yr target of $120.50.
Moat. PDD's durable competitive advantage stems from its high return on equity of 25.4%, driven by its pricing power and cost advantages in the Internet Retail sector. The company's 1.9 price-to-sales ratio and significant free cash flow generation enable it to invest in its business and maintain its market position. With a low beta of -0.03, PDD's stock price is less volatile than the overall market, indicating a stable business model.
Risk. PDD faces risks from its low analyst recommendation mean of 1.86, indicating a potential for downward revisions. Additionally, the company's 0.01 debt-to-equity ratio, while low, may not provide sufficient flexibility for future capital expenditures or acquisitions. The Internet Retail sector is also subject to fluctuations in consumer spending and preferences, which could impact PDD's revenue growth.
Horizon. 1-3 yr $120.50 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $113.84 at ~6% CAGR — dividend + buyback compounding. 10 yr $145.31 if the moat survives secular pressure.
3. BZ — KANZHUN LIMITED · score 97
Internet Content & Information · price $14.03 · 1Y $21.21 · 5Y $18.78 · 10Y $23.97
FCF $683m C+ · Rev +12.4% B+ · D/E 0.01 A · P/E 13.2x B+ · PEG 0.18 A
Why now. KANZHUN LIMITED, operating in the Internet Content & Information sector, presents an attractive setup with a current price of $14.03, a P/E of 13.2, and a revenue growth rate of 12.4%. The company's profit margin of 40.1% and FCF of $683m demonstrate its ability to generate cash. With an analyst consensus 1-yr target of $21.21, there's potential for significant upside.
Moat. KANZHUN LIMITED's durable competitive advantage stems from its ROE of 18.2%, which is driven by its ability to maintain a high profit margin in the Internet Content & Information sector. The company's low debt-to-equity ratio of 0.01 also provides flexibility for future investments, contributing to its moat. Additionally, its beta of 0.48 suggests a relatively stable stock performance compared to the market.
Risk. Key risks for KANZHUN LIMITED include its dependence on the Internet Content & Information sector, which can be subject to rapid changes in consumer behavior and technological advancements. The company's PEG ratio of 0.18 might indicate undervaluation, but it also poses the risk of potential multiple compression if growth slows. Furthermore, the analyst recommendation mean of 1.36 implies a strong buy consensus, which could lead to volatility if the company fails to meet expectations.
Horizon. 1-3 yr $21.21 (analyst consensus (n=21)) — multiple re-rating thesis requires a catalyst. 5 yr $18.78 at ~6% CAGR — dividend + buyback compounding. 10 yr $23.97 if the moat survives secular pressure.
4. INCY — Incyte Corporation · score 97
Biotechnology · price $102.38 · 1Y $107.96 · 5Y $137.01 · 10Y $174.88
FCF $1.4b C+ · Rev +21.2% A- · D/E 0.01 A · P/E 14.5x A- · PEG 0.36 A
Why now. Incyte Corporation, a biotechnology company, is undervalued given its 21.2% revenue growth rate and 26.7% profit margin. With a current price of $102.38 and a 14.5 P/E ratio, the company's valuation appears reasonable. The analyst consensus 1-yr target of $107.96 suggests a potential upside, driven by the company's strong financials and growth prospects.
Moat. Incyte's 30.8% ROE is driven by its ability to maintain high profit margins, likely due to its pricing power in the biotechnology sector. The company's 0.01 debt-to-equity ratio and $1.4b in free cash flow also contribute to its financial stability and ability to invest in growth initiatives. As a mid-cap biotechnology company, Incyte benefits from its diversified product portfolio and strong research and development capabilities.
Risk. Incyte faces risks related to its 0.79 beta, indicating a moderate level of market volatility. Additionally, the company's 3.8 P/S ratio is relatively high, which may indicate a potential valuation risk. Furthermore, the biotechnology sector is highly competitive, and Incyte must continue to innovate and invest in research and development to maintain its market position.
Horizon. 1-3 yr $107.96 (analyst consensus (n=24)) — multiple re-rating thesis requires a catalyst. 5 yr $137.01 at ~6% CAGR — dividend + buyback compounding. 10 yr $174.88 if the moat survives secular pressure.
5. ACN — Accenture plc · score 96
Information Technology Services · price $178.25 · 1Y $241.55 · 5Y $238.54 · 10Y $304.48
FCF $12.5b A- · Rev +7.4% B · D/E 0.25 B · P/E 14.6x A- · PEG 1.31 B
Why now. Accenture plc, a leading Information Technology Services provider, is undervalued given its 10.6% profit margin, $12.5b in free cash flow, and 7.4% revenue growth rate. With a current price of $178.25 and a P/E of 14.6, the company's valuation appears reasonable. The analyst consensus 1-yr target of $241.55 suggests a potential re-rating catalyst.
Moat. Accenture's durable competitive advantage stems from its high return on equity of 24.8%, driven by its ability to maintain pricing power in the Information Technology Services sector. The company's debt-to-equity ratio of 0.25 and significant free cash flow generation provide a cost advantage, allowing it to invest in its business and return value to shareholders.
Risk. Key risks for Accenture include its dependence on a few large clients, with a potential decline in revenue if these clients were to leave. Additionally, the company's beta of 1.07 indicates a moderate level of market risk, and its PEG ratio of 1.31 suggests that the stock may be somewhat overvalued relative to its growth rate.
Horizon. 1-3 yr $241.55 (analyst consensus (n=26)) — multiple re-rating thesis requires a catalyst. 5 yr $238.54 at ~6% CAGR — dividend + buyback compounding. 10 yr $304.48 if the moat survives secular pressure.
Speculative — asymmetric upside
1. BILL — BILL Holdings, Inc. · score 89
Software - Application · price $35.97 · 1Y $55.10 · 5Y $72.35 · 10Y $188.26
FCF $327m C · Rev +13.4% B+ · D/E 0.50 B · P/S 2.2x A- · PEG 0.38 A
Why now. BILL Holdings, Inc., a software application company, is currently trading at $35.97 with a 13.4% revenue growth rate and a 0.38 PEG ratio, indicating a potential for high growth. The company has a $327m free cash flow, which is a positive sign for its financial health. BILL sells software applications to various end markets, and its growth is driven by its ability to provide innovative solutions to its customers.
Moat. BILL's durable competitive advantage lies in its ability to generate $327m in free cash flow, which allows it to invest in research and development and expand its customer base. The company's 2.2 price-to-sales ratio is relatively low compared to its growth rate, indicating a potential for valuation expansion. BILL's business model is focused on providing software applications, which creates a moat due to high switching costs for its customers.
Risk. One of the major risks for BILL is its 1.18 beta, which indicates a high level of volatility in its stock price. Additionally, the company's 0.5 debt-to-equity ratio is a concern, as it may limit its ability to invest in growth opportunities. The company's 0% profit margin is also a risk, as it may indicate a lack of pricing power or high operating costs.
Horizon. 1-3 yr $55.10 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $72.35 — requires the platform / technology to reach commercial scale. 10 yr $188.26 — return distribution heavily skewed.
2. WIX — Wix.com Ltd. · score 89
Software - Infrastructure · price $52.39 · 1Y $86.05 · 5Y $105.38 · 10Y $274.20
FCF $505m C+ · Rev +13.2% B+ · D/E n/a · P/S 1.1x A · PEG 0.13 A
Why now. Wix.com Ltd., a software infrastructure company, is currently trading at $52.39 with a 13.2% revenue growth rate and a 0.13 PEG ratio, indicating a potential undervaluation. The company's $505m in free cash flow and 1.1 price-to-sales ratio suggest a reasonable valuation. As a high-risk, high-reward speculative play, Wix's growth is driven by its ability to provide website creation and hosting services to a wide range of customers.
Moat. Wix's moat lies in its ability to provide a user-friendly platform for website creation and hosting, with a 1.1 price-to-sales ratio indicating a strong market position. The company's focus on software infrastructure provides a cost advantage, allowing it to maintain a -2% profit margin while still generating significant free cash flow. Additionally, Wix's 0.9 beta suggests a relatively stable stock price, which could attract long-term investors.
Risk. The main risks facing Wix include intense competition in the software infrastructure sector, with a 0.13 PEG ratio indicating a potential for downward pressure on the stock price. Additionally, the company's -2% profit margin and lack of debt-to-equity ratio data may raise concerns about its financial health. Furthermore, the 19 analyst consensus and $54-$150 target range suggest a high level of uncertainty among investors.
Horizon. 1-3 yr $86.05 (analyst consensus (n=19)) — catalyst-driven; binary events dominate. 5 yr $105.38 — requires the platform / technology to reach commercial scale. 10 yr $274.20 — return distribution heavily skewed.
3. CRC — California Resources Corporation · score 87
Oil & Gas E&P · price $58.34 · 1Y $82.45 · 5Y $117.34 · 10Y $305.34
FCF $778m C+ · Rev +15.1% B+ · D/E 0.47 B · P/S 1.5x B+ · PEG 0.29 A
Why now. California Resources Corporation, an Oil & Gas E&P company, is currently trading at $58.34 with a 15.1% revenue growth rate and a 0.29 PEG ratio, indicating a potential for high growth. The company has a $778m free cash flow, which is a positive sign for its financial health. As a spec name, CRC's binary setup relies on its ability to execute on its growth strategy, with a potential upside driven by its $82.45 analyst consensus 1-yr target.
Moat. CRC's moat lies in its ability to generate cash flow in a sector with high barriers to entry, with a 1.5 price-to-sales ratio indicating a relatively low valuation. The company's 0.47 debt-to-equity ratio suggests a manageable debt level, allowing it to invest in its operations and maintain its competitive position. Additionally, its 0.9 beta indicates a relatively low volatility compared to the market.
Risk. The main risks for CRC include its -13.4% profit margin, which indicates a challenging operating environment, and its -14.4% ROE, which suggests a need for improvement in its returns on equity. Furthermore, the company's 0.47 debt-to-equity ratio, while manageable, still poses a risk if interest rates rise or the company's cash flow declines.
Horizon. 1-3 yr $82.45 (analyst consensus (n=11)) — catalyst-driven; binary events dominate. 5 yr $117.34 — requires the platform / technology to reach commercial scale. 10 yr $305.34 — return distribution heavily skewed.
4. BHC — Bausch Health Companies Inc. · score 85
Drug Manufacturers - Specialty & Generic · price $5.37 · 1Y $7.50 · 5Y $10.80 · 10Y $28.11
FCF $989m C+ · Rev +6.7% C+ · D/E n/a · P/S 0.2x A · PEG 0.01 A
Why now. Bausch Health Companies Inc., a specialty and generic drug manufacturer, is currently trading at $5.37 with a 6.7% revenue growth rate and a 0.2 price-to-sales ratio, indicating potential undervaluation. The company has a $989m free cash flow, which could be utilized to drive future growth. With an analyst consensus 1-year target of $7.50, there is a potential upside for investors.
Moat. Bausch Health's moat lies in its ability to generate significant free cash flow, with a 0.01 PEG ratio, indicating a low valuation relative to its growth rate. The company's 0.41 beta suggests a relatively low market risk, which could provide stability for investors. Additionally, its position in the specialty and generic drug manufacturing sector provides a foundation for potential long-term growth.
Risk. The main risks for Bausch Health include its -11.5% profit margin, which indicates current unprofitability, and the potential for regulatory changes to impact the company's operations. Furthermore, the lack of debt-to-equity ratio and ROE percentage may indicate potential financial instability or inefficiency. These risks must be carefully considered by investors.
Horizon. 1-3 yr $7.50 (analyst consensus (n=6)) — catalyst-driven; binary events dominate. 5 yr $10.80 — requires the platform / technology to reach commercial scale. 10 yr $28.11 — return distribution heavily skewed.
5. CNC — Centene Corporation · score 84
Healthcare Plans · price $62.33 · 1Y $60.06 · 5Y $125.37 · 10Y $326.22
FCF $7.1b B+ · Rev +19.4% B+ · D/E 0.76 C+ · P/S 0.2x A · PEG 1.15 B+
Why now. Centene Corporation, a mid-cap healthcare plans provider, is currently trading at $62.33 with a 19.4% revenue growth rate and a $7.1b free cash flow. The company's 1.15 PEG ratio indicates a potential for growth. As a spec name, CNC's binary setup relies on its ability to execute on its growth strategy, with a potential upside driven by its $30.8b market cap and 1.09 beta.
Moat. Centene Corporation's moat lies in its ability to generate $7.1b in free cash flow, which can be used to invest in its business and drive growth. The company's 0.2 price-to-sales ratio indicates a relatively low valuation, providing a potential cushion for investors. Additionally, its 0.76 debt-to-equity ratio suggests a manageable level of debt, allowing the company to maintain its financial flexibility.
Risk. Centene Corporation faces risks related to its -3.6% profit margin, which indicates a challenging operating environment. The company's -26% return on equity is also a concern, as it suggests that the company is not generating sufficient returns on its investments. Furthermore, the 1.09 beta indicates a higher level of volatility, making the stock more susceptible to market fluctuations.
Horizon. 1-3 yr $60.06 (analyst consensus (n=17)) — catalyst-driven; binary events dominate. 5 yr $125.37 — requires the platform / technology to reach commercial scale. 10 yr $326.22 — return distribution heavily skewed.
Methodology footnote
Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.